Peptide research, explained.
Mechanism primers, handling guides, and curated references for the compounds in our catalog. For educational and research use only.
Tesamorelin and Ipamorelin Blend
Tesamorelin and Ipamorelin blend facts you should know.
KLOW Blend
Understanding KLOW blend. Get the Facts!
Wolverine Blend
Understanding two peptides often requested. Get the facts!
Understanding BPC-157: The Body Protection Compound
Learn about one of the most researched peptides for tissue repair, gut health, and recovery.
GLP Agonists: Your Research Guide
Everything you need to know about GLP-1 medications for weight management and metabolic health.
BPC-157 Modulatory effects
Modulatory effects of BPC 157 on vasomotor tone and the activation of Src‑Caveolin‑1‑endothelial nitric oxide synthase pathway
Peptides Myths and Facts
Get the facts!
Peptides really are a game changer
Why are peptides so important to your health.
Understanding Peptides
A great review of peptides and what you need to know.
Peptides Benefits and Types
How to use Peptides
Semax Explained
Understand how Semax helps your brain
NAD Explained
What you need to know about NAD and your brain health.
Understanding Ipamorelin
Get the basics on Ipamorelin. How it works for you.
Tesamorelin Explained
Understand the benefits of Tesamorelin.
BPC-157 Explained
Understanding BPC-157. Separating fact from myths. It's a game changer
Cellgenic Exosomes
The Flow of Cellgenic Exosomes and the effect on your body
How Exosomes work
Exosomes and your Health
Optimizing Your Peptide Storage & Handling
Proper storage and handling ensures your peptide therapies remain effective and safe.
Nutrition Foundations for Peptide Therapy Success
Maximize your treatment outcomes with evidence-based nutrition strategies.
Building a Sustainable Exercise Routine
How to build and maintain an exercise program that complements your peptide therapy.
TB-500 — Clinical Reference
A synthetic fragment of thymosin β-4 used in research contexts for angiogenesis, tissue repair, and recovery across muscle, tendon, and ligament injuries.
Selank — Clinical Reference
A heptapeptide analogue of the immunomodulator tuftsin, developed at the Russian Academy of Sciences and approved in Russia for generalized anxiety.
Melanotan II — Clinical Reference
A synthetic cyclic heptapeptide analogue of α-MSH that activates melanocortin receptors, used in research contexts for pigmentation, appetite, and sexual function.
KPV — Clinical Reference
A C-terminal tripeptide of α-melanocyte-stimulating hormone (Lys-Pro-Val) with anti-inflammatory activity at epithelial surfaces, investigated in gut and skin protocols.
GHK-Cu — Clinical Reference
A copper-binding tripeptide (Gly-His-Lys) endogenous to human plasma, investigated for skin remodeling, wound healing, and hair regrowth.
Semax / Selank Blend — Clinical Reference
A combination of two Russian-developed heptapeptide nootropics — Semax (ACTH-derived) and Selank (tuftsin analogue) — formulated together for combined cognitive and anxiolytic endpoints.
Sermorelin — Clinical Reference
A 29-amino-acid synthetic analogue of the first 29 residues of human GHRH, formerly FDA-approved (Geref) for pediatric GH deficiency.
MOTS-c — Clinical Reference
A 16-amino-acid mitochondrial-derived peptide encoded in the 12S rRNA region of mtDNA, investigated as a metabolic regulator and exercise-mimetic.
Pinealon — Clinical Reference
A synthetic tripeptide (Glu-Asp-Arg) derived from the pineal-cortex bioregulator family, investigated for cognitive and anti-aging endpoints in Khavinson-school research.
Wolverine Blend — Clinical Reference
A proprietary multi-peptide formulation marketed for accelerated tissue repair and recovery. Composition varies by source — confirm components with your supplier before clinical use.
Thymulin — Clinical Reference
A zinc-bound nonapeptide thymic factor with immunomodulatory activity, investigated in research contexts for autoimmune and immune-deficiency endpoints.
Thymosin Alpha-1 (Tα1) — Clinical Reference
A 28-amino-acid thymic peptide immunomodulator approved in some countries (as Zadaxin) for hepatitis B/C and immune support in immunocompromised states.
Tesamorelin — Clinical Reference
A 44-amino-acid stabilized analogue of growth-hormone-releasing hormone (GHRH), FDA-approved as Egrifta for the reduction of excess abdominal fat in HIV-associated lipodystrophy.
SS-31 (Elamipretide) — Clinical Reference
A mitochondria-targeted tetrapeptide that binds cardiolipin and stabilizes mitochondrial cristae, investigated for mitochondrial myopathies and heart failure.
PT-141 (Bremelanotide) — Clinical Reference
A synthetic melanocortin-receptor agonist FDA-approved as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women; investigated for additional sexual-function indications.
PNC-27 — Clinical Reference (Investigational, Preclinical)
An investigational anti-cancer peptide chimera combining an HDM-2-binding domain with a cell-penetrating sequence. Not approved for clinical use; included here for reference only.
PE-22-28 — Clinical Reference
A short peptide TREK-1 ion-channel modulator investigated in depression and stroke-recovery preclinical research.
P-21 — Clinical Reference
A short IGF-1-derived peptide investigated for neurogenic and cognitive endpoints in preclinical research.
Oxytocin — Clinical Reference
A nine-amino-acid posterior-pituitary neurohormone with FDA-approved obstetric indications and active investigational use in social-cognition and anxiety research.
LL-37 — Clinical Reference
A 37-amino-acid cationic antimicrobial peptide derived from the human cathelicidin precursor hCAP-18, investigated for antimicrobial activity, wound healing, and immunomodulation.
Klow Blend — Clinical Reference
A proprietary multi-peptide formulation marketed for recovery and connective-tissue support. Composition varies by source — confirm components with your supplier before clinical use.
Kisspeptin — Clinical Reference
A hypothalamic neuropeptide and master regulator of the hypothalamic-pituitary-gonadal (HPG) axis, investigated for reproductive and neuroendocrine endpoints.
IGF-1 LR3 — Clinical Reference
A long-acting analogue of insulin-like growth factor 1 with reduced binding to IGFBPs and an extended plasma half-life, used in research contexts for anabolic and tissue-repair endpoints.
Human Chorionic Gonadotropin (HCG) — Clinical Reference
A placental glycoprotein hormone with luteinizing-hormone-like activity, used clinically in ovulation induction, male hypogonadism support, and cryptorchidism.
Glutathione — Clinical Reference
An endogenous tripeptide antioxidant (γ-glutamyl-cysteinyl-glycine) used in supportive contexts for oxidative-stress and detoxification pathways.
Glow Blend — Clinical Reference
A proprietary multi-peptide formulation marketed for skin, hair, and aesthetic endpoints. Composition varies by source — confirm components with your supplier before clinical use.
GHRP-6 — Clinical Reference
A synthetic hexapeptide GH-secretagogue closely related to GHRP-2, with more pronounced appetite-stimulating effects via the ghrelin pathway.
GHRP-2 (Pralmorelin) — Clinical Reference
A synthetic hexapeptide growth-hormone secretagogue (ghrelin-receptor agonist) that stimulates pulsatile GH release from the anterior pituitary.
FOX04-DRI — Clinical Reference
A D-retro-inverso peptide that disrupts the FOXO4–p53 interaction in senescent cells, investigated as a senolytic in preclinical aging research.
Epithalon — Clinical Reference
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal-gland polypeptide epithalamin, investigated for telomere biology and age-related endpoints.
DSIP (Delta Sleep-Inducing Peptide) — Clinical Reference
A nine-amino-acid neuropeptide first isolated from rabbit cerebral venous blood, investigated for sleep architecture, stress modulation, and analgesia.
Cagrilintide — Clinical Reference
A long-acting acylated analogue of amylin investigated for weight management, often paired with GLP-1 receptor agonists (e.g., CagriSema with GLP-1).
ARA-290 (Cibinetide) — Clinical Reference
An 11-amino-acid non-erythropoietic peptide derived from the helix-B domain of erythropoietin (EPO), studied for tissue protection and neuropathic pain.
AOD 9604 — Clinical Reference
A 16-amino-acid C-terminal fragment of human growth hormone (residues 177–191) investigated for its lipolytic activity without the somatogenic effects of the full peptide.